✦ LIBER ✦

Ambulatory treatment of metastatic melanoma associating subcutaneous dacarbazine, interferon α and interleukin-2

✍ Scribed by B. Dréno; D. Cupissol; P. Joly; B. Sassolas; T. Bonneterre; J.M. Tourani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous recombinant interleukin-2 p

✍ M. Guida; A. Latorre; A. Mastria; M. De Lena 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 395 KB

214 Fotemustine, dacarbazine (DTIC) and

✍ P. Comella; F. Presutti; A. Daponte; R. Casaretti; G. Frasci; G. Palmieri; R. Ga 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A phase II study of dacarbazine, cisplat

✍ T.M. Proebstle; C. Scheibenbogen; W. Sterry; U. Keilholz 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 452 KB

Chemoimmunotherapy of advanced malignant

✍ J. Atzpodien; E. Lopez Hänninen; H. Kirchner; A. Franzke; A. Körfer; M. Volkenan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 440 KB

Combined treatment with pegylated interf

✍ Axel Hauschild; Reinhard Dummer; Selma Ugurel; Katharina C. Kaehler; Friederike 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Adding interleukin 2 to dacarbazine and

✍ Robert O Dillman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 201 KB